Observational study examines factors affecting chemotherapy dose reductions in breast cancer, suggesting implications for treatment practices.
Clinician- and facility-level factors were associated with chemotherapy dose reductions. Practice-level changes, such as increasing breast cancer patient volumes and practice size, may support optimal dosing practices.
No takes yet. Share an insight, caveat, or question.
Sampathkumar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: